ArticleJournal of agricultural and food chemistry2026
Oleic Acid-Esterified Octacosanol as a Functional Ingredient to Counter Obesity-Associated Lipid Dysregulation through PPAR-Targeted Regulation.
Article in Journal of agricultural and food chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Octacosanol: A Natural Bioactive Ingredient for Atherosclerosis Prevention and Cardiovascular Health Promotion.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Octacosanol, a major constituent of policosanol, exhibits lipid-lowering activity, particularly when esterified with fatty acids. Although its cholesterol-lowering actions have been linked to the modulation of fatty acid and cholesterol biosynthesis, its functions within adipose tissue remain poorly defined. Here, we examined nonesterified octacosanol (NO), lauric acid-esterified octacosanol (LEO), and oleic acid-esterified octacosanol (OEO) in high-fat diet-fed mice for 11 weeks. Target prediction and molecular docking identified PPARα and PPARδ as putative targets of octacosanol, guiding downstream mechanistic analyses in adipose tissue. Both NO and OEO enhanced lipolysis; NO preferentially increased fatty acid β-oxidation, whereas OEO specifically promoted thermogenic remodeling, indicating distinct metabolic consequences driven by ester chemistry. Together, these findings demonstrate that structural modification, particularly oleic acid esterification, substantially augments the metabolic activity of octacosanol in lipid catabolism and thermogenesis, underscoring its potential relevance in obesity-associated metabolic regulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.